Bausch Health
BHC
#3588
Rank
โ‚ฌ2.87 B
Marketcap
7,81ย โ‚ฌ
Share price
-0.12%
Change (1 day)
23.42%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ20.53 Billion

According to Bausch Health 's latest financial reports the company's total debt is โ‚ฌ20.53 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bausch Health - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ20.25 B4.61%
2022-12-31โ‚ฌ19.35 B-3.22%
2021-12-31โ‚ฌ20.00 B2.84%
2020-12-31โ‚ฌ19.45 B-15.85%
2019-12-31โ‚ฌ23.11 B8.8%
2018-12-31โ‚ฌ21.24 B0.19%
2017-12-31โ‚ฌ21.20 B-25.26%
2016-12-31โ‚ฌ28.37 B-0.25%
2015-12-31โ‚ฌ28.44 B127.09%
2014-12-31โ‚ฌ12.52 B-0.46%
2013-12-31โ‚ฌ12.58 B50.98%
2012-12-31โ‚ฌ8.33 B62.76%
2011-12-31โ‚ฌ5.12 B84.54%
2010-12-31โ‚ฌ2.77 B913.57%
2009-12-31โ‚ฌ0.27 B500.91%
2008-12-31โ‚ฌ45.56 M
2006-12-31โ‚ฌ0.31 B-15.64%
2005-12-31โ‚ฌ0.36 B4.45%
2004-12-31โ‚ฌ0.35 B-45.29%
2003-12-31โ‚ฌ0.64 B-9.73%
2002-12-31โ‚ฌ0.71 B1267.8%
2001-12-31โ‚ฌ52.26 M-93.33%
2000-12-31โ‚ฌ0.78 B473.86%
1999-12-31โ‚ฌ0.13 B27.78%
1998-12-31โ‚ฌ0.10 B2489.8%
1997-12-31โ‚ฌ4.12 M-30%
1996-12-31โ‚ฌ5.89 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.25 B-98.75%๐Ÿ‡บ๐Ÿ‡ธ USA